First Time Loading...

Gilead Sciences Inc
NASDAQ:GILD

Watchlist Manager
Gilead Sciences Inc Logo
Gilead Sciences Inc
NASDAQ:GILD
Watchlist
Price: 67.86 USD 1.27%
Updated: May 16, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

56.3B
-9%
Assets
Growth Rates:
1 Year
-9%
3 Years
-17%
5 Years
-10%
7 Years
-2%
10 Years
+100%
38.8B
-1%
Liabilities
Growth Rates:
1 Year
-5%
3 Years
-20%
5 Years
-5%
7 Years
+4%
10 Years
+164%
17.5B
-24%
Equity
Growth Rates:
1 Year
-17%
3 Years
-8%
5 Years
-20%
7 Years
-15%
10 Years
+30%

Balance Sheet Decomposition
Gilead Sciences Inc

56.3B
Assets
38.8B
Liabilities
56.3B
Assets
38.8B
Liabilities
Current Assets 12.8B
Cash & Short-Term Investments 4.7B
Receivables 4.7B
Other Current Assets 3.4B
Non-Current Assets 43.5B
PP&E 5.3B
Intangibles 31.7B
Other Non-Current Assets 6.5B
Current Liabilities 13B
Other Current Liabilities 13B
Non-Current Liabilities 25.8B
Other Non-Current Liabilities 25.8B

Balance Sheet
Gilead Sciences Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
10 027
12 851
8 229
7 588
17 940
11 631
5 997
5 338
5 412
8 428
Cash Equivalents
10 027
12 851
8 229
7 588
17 940
11 631
5 997
5 338
5 412
8 428
Short-Term Investments
101
1 757
3 666
17 922
12 149
12 721
1 411
1 182
973
1 179
Total Receivables
4 635
5 854
4 514
3 851
3 327
3 582
4 892
4 493
4 777
4 660
Accounts Receivables
4 635
5 854
4 514
3 851
3 327
3 582
4 892
4 493
4 777
4 660
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
1 386
1 955
1 587
801
814
922
1 683
1 618
1 507
1 787
Other Current Assets
1 565
2 345
1 592
1 661
1 606
1 440
2 013
2 141
1 774
2 374
Total Current Assets
17 714
24 762
19 588
31 823
35 836
30 296
15 996
14 772
14 443
16 085
PP&E Net
1 674
2 276
2 865
3 295
4 006
5 170
5 613
5 663
5 475
5 317
PP&E Gross
1 674
2 276
0
3 295
4 006
5 170
5 613
5 663
5 475
5 317
Accumulated Depreciation
620
763
0
994
1 191
1 422
1 668
1 893
2 186
2 449
Intangible Assets
11 073
10 247
8 971
17 100
15 738
13 786
33 126
33 455
28 894
26 454
Goodwill
1 172
1 172
1 172
4 159
4 117
4 117
8 108
8 332
8 314
8 314
Long-Term Investments
1 598
11 601
20 495
11 194
1 423
1 488
502
1 309
1 245
1 163
Other Long-Term Assets
1 433
1 658
3 886
2 712
2 555
6 770
5 062
4 421
4 800
4 792
Other Assets
1 172
1 172
1 172
4 159
4 117
4 117
8 108
8 332
8 314
8 314
Total Assets
34 664
N/A
51 716
+49%
56 977
+10%
70 283
+23%
63 675
-9%
61 627
-3%
68 407
+11%
67 952
-1%
63 171
-7%
62 125
-2%
Liabilities
Accounts Payable
955
1 178
1 206
814
790
713
844
705
905
550
Accrued Liabilities
4 084
7 257
7 775
7 271
6 876
6 254
7 198
7 600
7 100
7 724
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
483
982
0
2 747
2 748
2 499
2 757
1 516
2 273
1 798
Other Current Liabilities
239
473
237
803
191
293
598
1 789
959
1 208
Total Current Liabilities
5 761
9 890
9 218
11 635
10 605
9 759
11 397
11 610
11 237
11 280
Long-Term Debt
11 936
21 075
26 346
30 795
24 574
22 094
28 645
25 179
22 957
23 189
Deferred Income Tax
51
0
0
0
0
0
0
4 356
2 673
1 588
Minority Interest
393
579
476
59
147
125
19
5
31
84
Other Liabilities
1 097
1 638
2 050
7 352
6 962
7 124
10 144
5 743
5 095
3 319
Total Liabilities
19 238
N/A
33 182
+72%
38 090
+15%
49 841
+31%
42 288
-15%
39 102
-8%
50 205
+28%
46 883
-7%
41 931
-11%
39 292
-6%
Equity
Common Stock
2
1
1
1
1
1
1
1
1
1
Retained Earnings
12 732
18 001
18 154
19 012
19 024
19 388
14 381
16 324
15 687
16 304
Additional Paid In Capital
2 391
444
454
1 264
2 282
3 051
3 880
4 661
5 550
6 500
Unrealized Security Profit/Loss
12
16
16
194
52
1
2
4
33
5
Other Equity
289
104
294
29
132
84
62
87
35
33
Total Equity
15 426
N/A
18 534
+20%
18 887
+2%
20 442
+8%
21 387
+5%
22 525
+5%
18 202
-19%
21 069
+16%
21 240
+1%
22 833
+8%
Total Liabilities & Equity
34 664
N/A
51 716
+49%
56 977
+10%
70 283
+23%
63 675
-9%
61 627
-3%
68 407
+11%
67 952
-1%
63 171
-7%
62 125
-2%
Shares Outstanding
Common Shares Outstanding
1 499
1 422
1 307
1 308
1 282
1 266
1 254
1 254
1 247
1 246

See Also

Summary
GILD intrinsic value, competitors valuation, and company profile.
DCF Valuation
GILD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GILD stock valuation using valuation multiples.
Wall Street Estimates
GILD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GILD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.